Cite
Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL.
MLA
Decker, Sarah, et al. “Trisomy 12 and Elevated GLI1 and PTCH1 Transcript Levels Are Biomarkers for Hedgehog-Inhibitor Responsiveness in CLL.” Blood, vol. 119, no. 4, Jan. 2012, pp. 997–1007. EBSCOhost, https://doi.org/10.1182/blood-2011-06-359075.
APA
Decker, S., Zirlik, K., Djebatchie, L., Hartmann, D., Ihorst, G., Schmitt-Graett, A., Herchenbach, D., Jumaa, H., Warmuth, M., Veelken, H., & Dierks, C. (2012). Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL. Blood, 119(4), 997–1007. https://doi.org/10.1182/blood-2011-06-359075
Chicago
Decker, Sarah, Katja Zirlik, Lauritte Djebatchie, David Hartmann, Gabriele Ihorst, Annette Schmitt-Graett, Dieter Herchenbach, et al. 2012. “Trisomy 12 and Elevated GLI1 and PTCH1 Transcript Levels Are Biomarkers for Hedgehog-Inhibitor Responsiveness in CLL.” Blood 119 (4): 997–1007. doi:10.1182/blood-2011-06-359075.